BACKGROUND: Indocyanine green (ICG) clearance has been proposed as a quantitative liver function test several decades ago. Interest in this method has been renewed following the development of finger pulse densitometry for noninvasive estimation of the ICG plasma disappearance rate (PDR). On the other hand, the model for end-stage liver disease (MELD), which is based on routine laboratory parameters, is widely used for estimation of short-term survival in cirrhosis, but its prognostic value in critically ill cirrhotic patients is unclear. AIMS: The aim of the present study was to compare the diagnostic accuracy of ICG PDR vs. MELD for estimation of short-term prognosis in cirrhotic patients. METHODS: Ninety consecutive cirrhotic patients who were admitted for decompensated disease or were being evaluated for liver transplantation were screened. Patients who underwent liver transplantation within the following 90 days and those with hepatocellular carcinoma were excluded. In the remaining 70 patients, routine laboratory parameters and ICG clearance were analysed. Following an injection of ICG 0.25 mg/kg, PDR was measured by finger pulse densitometry. The diagnostic accuracy of ICG PDR and MELD for prediction of 90-day survival was assessed by receiver-operating characteristic (ROC) curve analysis. RESULTS: ROC curve analysis revealed superior diagnostic accuracy for MELD as compared with ICG PDR in predicting 90-day survival (area under the ROC curve 0.89 vs. 0.71). A MELD cut-off of 22 provided the best discrimination for prediction of 90-day survival. CONCLUSIONS: MELD is superior to ICG PDR for estimation of short-term survival in patients with decompensated cirrhosis.
BACKGROUND:Indocyanine green (ICG) clearance has been proposed as a quantitative liver function test several decades ago. Interest in this method has been renewed following the development of finger pulse densitometry for noninvasive estimation of the ICG plasma disappearance rate (PDR). On the other hand, the model for end-stage liver disease (MELD), which is based on routine laboratory parameters, is widely used for estimation of short-term survival in cirrhosis, but its prognostic value in critically ill cirrhoticpatients is unclear. AIMS: The aim of the present study was to compare the diagnostic accuracy of ICGPDR vs. MELD for estimation of short-term prognosis in cirrhotic patients. METHODS: Ninety consecutive cirrhotic patients who were admitted for decompensated disease or were being evaluated for liver transplantation were screened. Patients who underwent liver transplantation within the following 90 days and those with hepatocellular carcinoma were excluded. In the remaining 70 patients, routine laboratory parameters and ICG clearance were analysed. Following an injection of ICG 0.25 mg/kg, PDR was measured by finger pulse densitometry. The diagnostic accuracy of ICGPDR and MELD for prediction of 90-day survival was assessed by receiver-operating characteristic (ROC) curve analysis. RESULTS: ROC curve analysis revealed superior diagnostic accuracy for MELD as compared with ICGPDR in predicting 90-day survival (area under the ROC curve 0.89 vs. 0.71). A MELD cut-off of 22 provided the best discrimination for prediction of 90-day survival. CONCLUSIONS: MELD is superior to ICGPDR for estimation of short-term survival in patients with decompensated cirrhosis.
Authors: Tony J Akl; Travis J King; Ruiqi Long; Michael J McShane; M Nance Ericson; Mark A Wilson; Gerard L Coté Journal: J Biomed Opt Date: 2012-07 Impact factor: 3.170
Authors: Mikhail A Proskurnin; Tatyana V Zhidkova; Dmitry S Volkov; Mustafa Sarimollaoglu; Ekaterina I Galanzha; Donald Mock; Dmitry A Nedosekin; Vladimir P Zharov Journal: Cytometry A Date: 2011-09-08 Impact factor: 4.355
Authors: Stefanie Haegele; Silvia Reiter; David Wanek; Florian Offensperger; David Pereyra; Stefan Stremitzer; Edith Fleischmann; Christine Brostjan; Thomas Gruenberger; Patrick Starlinger Journal: PLoS One Date: 2016-11-03 Impact factor: 3.240
Authors: Matthias Klingele; Theresa Stadler; Danilo Fliser; Timo Speer; Heinrich V Groesdonk; Alexander Raddatz Journal: Crit Care Date: 2017-11-29 Impact factor: 9.097
Authors: Thomas Horvatits; Nikolaus Kneidinger; Andreas Drolz; Kevin Roedl; Karoline Rutter; Stefan Kluge; Michael Trauner; Valentin Fuhrmann Journal: Ann Intensive Care Date: 2015-12-04 Impact factor: 6.925
Authors: Tomasz Dziodzio; Robert Öllinger; Wenzel Schöning; Antonia Rothkäppel; Radoslav Nikolov; Andrzej Juraszek; Paul V Ritschl; Martin Stockmann; Johann Pratschke; Maximilian Jara Journal: BMC Gastroenterol Date: 2020-08-12 Impact factor: 3.067